Delivery Order SPE2DB22D2218-SPE2DB25FR3KS
- Not listed
- The Defense Logistics Agency awarded a $5,877.92 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitive award, which carries a firm fixed price structure and an ultimate completion date of September 19, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and specifies...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitive, non-set-aside delivery order has a ceiling value of $6,266.60 and is scheduled for completion by September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a $13,451.77 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed price contract has a completion date of July 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with a contract ceiling value of $5,708.57 and an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, valued at $9,752.90. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a contract ceiling value of $2,795.15 and an ultimate completion date of June 3, 2025. The delivery order is a non-set-aside, competitively awarded contract with firm fixed pricing, classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on September 4, 2025, with an ultimate completion date of September 5, 2025. The order, valued at $4,540.22 under a firm fixed price contract type, covers Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. The award involved no set-aside designation and was competitively awarded. Performance of this delivery order is based at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 20, 2025, by the Defense Logistics Agency for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities, with a contract value of $11,350.99 and an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procurement. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a contract ceiling value of $34,924.93. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $11,570.41 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 25, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3KSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) injectable medication, with a firm fixed price ceiling value of $44,584.44 and an ultimate completion date of September 29, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in fulfilling federal medical procurement requirements across multiple therapeutic domains. The company's extensive federal contract portfolio with the Defense Logistics Agency includes delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities supporting military and veteran healthcare systems. This Ozempic delivery order exemplifies the company's role as a critical vendor within the federal medical supply chain, providing diabetes medications and other essential pharmaceuticals to support the Department of Defense's healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.6k | 9/26/25 |